TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $988,162 | +9.9% | 63,876 | +11.6% | 0.02% | +16.7% |
| Q2 2023 | $899,366 | -29.1% | 57,248 | -25.6% | 0.02% | -30.8% |
| Q1 2023 | $1,268,268 | +17.0% | 76,958 | +10.8% | 0.03% | +18.2% |
| Q4 2022 | $1,083,779 | +8.1% | 69,473 | -10.2% | 0.02% | +4.8% |
| Q3 2022 | $1,003,000 | +4.4% | 77,360 | +13.1% | 0.02% | +16.7% |
| Q2 2022 | $961,000 | -15.3% | 68,420 | -13.7% | 0.02% | +5.9% |
| Q1 2022 | $1,135,000 | +39.8% | 79,263 | +33.1% | 0.02% | +41.7% |
| Q4 2021 | $812,000 | -21.2% | 59,563 | -5.3% | 0.01% | -25.0% |
| Q3 2021 | $1,030,000 | +14.2% | 62,884 | +17.3% | 0.02% | +23.1% |
| Q2 2021 | $902,000 | +12.8% | 53,607 | +22.4% | 0.01% | +8.3% |
| Q1 2021 | $800,000 | +79.4% | 43,796 | +78.6% | 0.01% | +71.4% |
| Q4 2020 | $446,000 | +48.2% | 24,528 | +45.3% | 0.01% | +16.7% |
| Q3 2020 | $301,000 | +246.0% | 16,878 | +247.7% | 0.01% | +200.0% |
| Q2 2020 | $87,000 | – | 4,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |